Subscribe
24NEWSHOUR 24NEWSHOUR
Write For Us
  • Home
  • Business
  • Education
  • Entertainment
  • News Update
  • Others
    • Technology
    • Health & Lifestyle
  • Write For US
  1. Home
  2. Business
  3. Amrit AG, a Partex NV company, and YouWeCan Cancer Foundation come together to celebrate milestones in access to treatment for cancer patients
Business News Update

Amrit AG, a Partex NV company, and YouWeCan Cancer Foundation come together to celebrate milestones in access to treatment for cancer patients

 Amrit AG, a Partex NV company, and YouWeCan Cancer Foundation come together to celebrate milestones in access to treatment for cancer patients

Partex NV, the digital pharma platform helping revolutionize the healthcare industry with Data to Drugs, recently organized a mega event at By the Mekong, St. Regis. The event celebrated Curia App for cancer patients by Amrit and its successful partnership with YouWeCan Cancer Foundations for the common cause.

The event marked the presence of international cricketer, entrepreneur, and the founder of YouWeCan Yuvraj Singh, serial entrepreneur and investor Francisco Fernandez and the CEO of Partex NV, Dr. Gunjan Bhardwaj. Other celebrity guests who attended include Actor and Entrepreneur Suniel Shetty, Cricketer Graeme Smith, Cricketer Mark Boucher, Football Coach Sol Campbell, actor Angad Bedi, Cricketer Ashish Nehra, Actor / Anchor Rannvijay Singha, Director/Producer Abhishek Kapoor and Model / Producer Pragya Kapoor, Actor / Cricket presenter Gaurav Kapur, Actor Mallika Sherawat, Actor Neha Sharma, Actor Saiyami Kher, Cricketer Zaheer Khan, and wife Sagarika Ghatge, Ajit Agarkar and his wife and many more.

As the most significant cause of fatalities in India and almost all major countries, cancer is not only life-threatening but also marred by misinformation and lack of access to quality care. Patients do not receive timely and effective care without authentic information and guidance. This means additional costs for below-par treatment for them.

Partex is a platform that contributes to the entire healthcare value chain, from operating the world’s largest RWD ecosystem to developing in-house drug assets. By leveraging artificial intelligence and blockchain technology, Partex is innovating for patients, customers, and partners on different levels to increase Humanity’s Health and Longevity. The joint mission of the two entities is to support underprivileged cancer patients from across the country to get access to quality and affordable treatment and support.

Speaking at the event, Gunjan Bhardwaj, CEO of Partex, said, “It is a moment of reckoning for us to celebrate this success here with AMRIT and YouWeCan Organisation. With Curia, we empower patients to get involved with the cancer community and cancer research. With the vision of improving human health and longevity, AMRIT wants to make research democratic and accessible for patients who need it most.  We thank Yuvraj Singh for his continued support and encouragement.”

Yuvraj Singh added his thoughts: “Life has come full circle for me today as someone who has battled cancer. I have always wanted to ensure that those with this condition can access quality, affordable, timely treatment and support. Partex has been doing some amazing work in this regard, and we celebrate the milestones today, only to ensure that we carry the work forward further in the times ahead.”

Francisco Fernandez, Chairman of Partex, added, “Cancer is not just a health condition but impacts a person’s financial and social aspects. It is a double whammy for victims of misinformation and lack of economic strength to get treated. Our efforts have been to eliminate this challenge and ensure equity in access to affordable treatment over the period since we started.”

Over the past five years, Partex has built the world’s largest data ocean with public and private data and Amrit (www.amrit.ai): a real-world data ecosystem. With Amrit, Partex transforms the healthcare industry through data licensing and incentivizing patients. The Amrit Marketplace is established to find a cure for incurable diseases, involving and rewarding patients in an equitable system. The vision is to put patients at the heart of the solution.

With more than 500 employees globally, Partex is a data-to-drugs, digital pharma platform spread across Germany, Switzerland, the USA, and India.

Previous post
Next post

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • DEE DEVELOPMENT ENGINEERS LIMITED FILES DRHP WITH SEBI
  • AGILUS DIAGNOSTICS LIMITED FILES DRHP WITH SEBI
  • Vi Introduces Data Sharing and Night Time Unlimited Data into Vi Max Family Postpaid Plans
  • Gem & Jewellery industry pledges to enhance Trust, Transparency, Sustainability, Traceability & Responsible Sourcing thru’ self-regulation
  • AZAD ENGINEERING LIMITED FILES DRHP WITH SEBI
Latest News
Business

DEE DEVELOPMENT ENGINEERS LIMITED FILES DRHP WITH SEBI

October 4, 2023
Business

AGILUS DIAGNOSTICS LIMITED FILES DRHP WITH SEBI

October 4, 2023
Business

Vi Introduces Data Sharing and Night Time Unlimited Data into

October 4, 2023
Business

Gem & Jewellery industry pledges to enhance Trust, Transparency, Sustainability,

October 3, 2023
24NEWSHOUR 24NEWSHOUR

Get The Post

Business
Education
News Update

Quick Links

About Us
The News Strike
The News Equity

Follow Us

© Copyright 2023. All rights reserved.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}